A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
Clinical trial NCT04399551 · COMPLETED
Trial details
- NCT number
- NCT04399551
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2022-03-07
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.